Brixmor Property, the Real Estate sector company, was revisited by a Wall Street analyst yesterday. Analyst Juan C. Sanabria from BMO Capital maintained a Buy rating on the stock and has a $32.00 price target.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Juan C. Sanabria has given his Buy rating due to a combination of factors tied to Brixmor’s strong operating performance and earnings outlook. The company delivered a solid fourth quarter, with same‑store net operating income growing materially faster than peers, driven largely by higher base rents and ancillary income. Robust leasing activity, particularly for in‑line space, pushed the in‑line leased rate to a record level, underscoring healthy tenant demand and supporting continued internal growth.
The signed‑not‑opened pipeline also expanded, providing additional embedded rent and downside protection for future periods. Management’s 2026 FFO guidance landed essentially in line with Street and BMO estimates, yet is underpinned by above‑peer expectations for same‑store NOI growth, creating room for upside to earnings. Credit quality trends are stable, with uncollectible lease income improving versus early 2025, reinforcing the durability of cash flows. Taken together, these factors support Sanabria’s view that the shares should respond favorably and remain attractive at current levels.
According to TipRanks, C. Sanabria is a 3-star analyst with an average return of 1.9% and a 50.97% success rate. C. Sanabria covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, Welltower, and Omega Healthcare.